Atlas Trials

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Clinical trial NCT04374630 · COMPLETED

Trial details

NCT number
NCT04374630
Sponsor
Laekna Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Platinum-resistant Ovarian Cancer
Start date
2020-06-09
Primary completion
2023-07-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.